drugset / Trial / NCT06476899

A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy

NCT06476899

Phase 2 Not yet recruiting 60 enrolled Fei Li
Non-randomizedParallel-groupOpen-labelOther

Summary

Prospective, interventional, and practical clinical studies

Timeline

Start
2024-07-24
Primary completion
2026-03-26
Completion
2026-12-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Orelabrutinib Small molecule